In conclusion, WFDC12 may promote the accumulation of PAF by regulating enzyme activity and activating the lipoxygenase pathway of AA metabolism to promote the production of inflammatory lipid mediators, thus participating in the immune inflammatory response in AD pathogenesis and regulating AD progression. Here, WFDC12 is linked to Alzheimer disease.